Bleeding That Won't Stop

Annals of Thoracic Surgery

Volumn 85, Issue 4, 2008, Pages 1153-1154

  Edmunds Jr , L Henry ^a   Colman, Robert W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 7; D DIMER; FRESH FROZEN PLASMA; HIRULOG; PLASMIN INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD CLOTTING DISORDER; CARDIOPULMONARY BYPASS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE TITRATION; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HEART SURGERY; HUMAN; INJURY; NEOPLASM; PRIORITY JOURNAL; SEPSIS; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

BLOOD COAGULATION DISORDERS; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COAGULANTS; CORONARY ARTERY BYPASS; HUMANS; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PRIMARY PREVENTION; PROGNOSIS;

EID: 40749111860     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.02.028     Document Type: Editorial

References (16)

1. Gram J., Janetko T., Jeppsson J., and Bruhn H.D. Enhanced effective fibrinolysis following neutralization of heparin in open heart surgery increases the risk of post surgical bleeding. Thromb Haemost 63 (1990) 241-245
2. Brister S.J., Ofosu F.A., and Buchanan M.R. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?. Thromb Haemost 70 (1993) 259-262
3. Weitz J.I., Hudoba M., Massel D., et al. Clot-bound thrombin is protected from inhibition by heparin- antithrombin III-independent inhibitors. J Clin Invest 86 (1990) 385-391
4. Chung J.H., Gikakis N., Drake T.A., Colman R.W., and Edmunds Jr. L.H. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 93 (1996) 2014-2018
5. Edmunds Jr. L.H., and Colman R.W. Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82 (2006) 2315-2322
6. Hattori T., Khan M.M.H., Colman R.W., and Edmunds Jr. L.H. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds. J Am Coll Cardiol 46 (2005) 707-713
7. Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost 43 (1980) 77-89
8. Longstaff C. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 5 (1994) 537-542
9. Ferraris V.A., Ferraris S.P., Saha S.P., et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg 83 (2007) S27-S86
10. Brown J.R., Birkmeyer N.J.O., and O'Connor G.T. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115 (2007) 2801-2813
11. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. New Engl J Med 357 (2007) 885-896
12. Roberts H.R., Monroe D.M., and White G.C. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 104 (2004) 3858-3864
13. Mann K.G., Brummel K., and Butenas S. What is all that thrombin for?. J Thromb Haemost 1 (2003) 1504-1514
14. Cammerer U., Dietrich W., Rampf T., et al. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 96 (2003) 51-57
15. Gladwell T.D. Bivalirudin: a direct thrombin inhibitor. Clin Ther 1 (2002) 38-58
16. Levin E.G., and Santell I. Stimulation and desensitization of tissue plasminogen activator release from human endothelial cells. J Biol Chem 263 (1988) 9360-9365